ZKSCAN3 and prostate cancer: These results not only support epidemiological data indicating an association between vasectomy and subsequent prostate cancer risk but may also offer a potential chemopreventive or therapeutic strategy for prostate cancer, via targeting ZKSCAN3 signaling, especially in vasectomized men.